Covered recipient · General Payments record
VICTORIA C GODDARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,720.01
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $513.93 | 14 |
| Education | $115.26 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $282.32 | 4 |
| Janssen Biotech, Inc. | $99.99 | 1 |
| Amgen Inc. | $80.82 | 3 |
| PFIZER INC. | $59.19 | 3 |
| Galderma Laboratories, L.P. | $36.11 | 2 |
| Regeneron Healthcare Solutions, Inc. | $26.56 | 1 |
| Incyte Corporation | $25.79 | 1 |
| Dermavant Sciences, Inc. | $18.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $27.88 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117563630 | CMS |
| Amgen Inc. | $25.92 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117563632 | CMS |
| Amgen Inc. | $27.02 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117563634 | CMS |
| Dermavant Sciences, Inc. | $18.41 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127976012 | CMS |
| Galderma Laboratories, L.P. | $20.51 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359914 | CMS |
| Galderma Laboratories, L.P. | $15.60 | 09/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359916 | CMS |
| Incyte Corporation | $25.79 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141240872 | CMS |
| Janssen Biotech, Inc. | $99.99 | 01/17/2024 | Education | Undisputed | 01/23/2026 | 1078805827 | CMS |
| Lilly USA, LLC | $18.41 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135988964 | CMS |
| Lilly USA, LLC | $121.59 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135983870 | CMS |
| Lilly USA, LLC | $121.85 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135984238 | CMS |
| Lilly USA, LLC | $20.47 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135988606 | CMS |
| PFIZER INC. | $23.33 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131256831 | CMS |
| PFIZER INC. | $20.59 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131472127 | CMS |
| PFIZER INC. | $15.27 | 07/25/2024 | Education | Undisputed | 01/23/2026 | 1131674270 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.56 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114306924 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.